17
мар
LOUIS --(Business Wire)-- Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announces availability of a 60-day free trial of Phoenix® Connect™, a reporting tool for existing Phoenix WinNonlin® users. Phoenix Connect provides integrated, automatic report compilation, replacing existing, error-prone manual processes for copying and pasting tables, listings and figures into Microsoft ( - )® Word®. As a result, clinical trial teams can have confidence that their periodic reporting will be error-free and will not impede drug development processes and regulatory milestones. 
This software solution benefits pharmaceutical and biotech R&D and clinical trial staff by offering: • Integrated connectivity between Phoenix workflows and external applications • Seamless, error-free reporting, modeling and data management • Enhanced compliance and speed to market • Minimized regulatory risk ad costly exposure resulting from data errors • Time savings associated with manual report generation (reducing effort from hours to minutes). 'While Phoenix Connect saves clinical trial teams vast amounts of time, its real value is in the way it ensures error-free data in both interim and final reports.
That result has a positive impact on the business: fewer data errors means less risk at regulatory milestones and greater chance that drugs in development get to market faster and without data-related regulatory issues,' said James Hayden, senior vice president, global sales and marketing. 'It's competitive edge in a box.' WinNonlin users can request a free 60-day trial by contacting +1 (919) 852-4685 or visiting. About Certara Certara is dedicated to improving human health through a broad spectrum of software products and consulting services, from molecular discovery through clinical development, with special focus on supporting translational approaches to drug development. Certara was formed by the acquisition and integration of industry leaders Tripos ( - )®, Simcyp™, and Pharsight® Corporation. Each Certara family brand focuses on a key phase within the drug discovery and development process; combined, they offer a unique set of scientific modeling, analysis, and simulation capabilities that can enable the cross-disciplinary approaches necessary for translational science initiatives. For more information, visit.
Are you currently using Excel for PK/TK analysis? We will show how to leverage Phoenix WinNonlin to streamline all of the analyses and generate all of the output needed for noncompartmental analysis, TK, PK and PK/PD studies from within a single, validatable environment. Highlights of this interactive workshop will include: • Sophisticated plotting of PK data • Calculation of key PK parameters Cmax, Tmax, AUClast, AUCinf, Clearance • Statistical summary of PK parameters in a presentation-quality report table • Save repetitive steps with re-usable analysis templates.
Popular Posts
LOUIS --(Business Wire)-- Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announces availability of a 60-day free trial of Phoenix® Connect™, a reporting tool for existing Phoenix WinNonlin® users. Phoenix Connect provides integrated, automatic report compilation, replacing existing, error-prone manual processes for copying and pasting tables, listings and figures into Microsoft ( - )® Word®. As a result, clinical trial teams can have confidence that their periodic reporting will be error-free and will not impede drug development processes and regulatory milestones.
This software solution benefits pharmaceutical and biotech R&D and clinical trial staff by offering: • Integrated connectivity between Phoenix workflows and external applications • Seamless, error-free reporting, modeling and data management • Enhanced compliance and speed to market • Minimized regulatory risk ad costly exposure resulting from data errors • Time savings associated with manual report generation (reducing effort from hours to minutes). \'While Phoenix Connect saves clinical trial teams vast amounts of time, its real value is in the way it ensures error-free data in both interim and final reports.
That result has a positive impact on the business: fewer data errors means less risk at regulatory milestones and greater chance that drugs in development get to market faster and without data-related regulatory issues,\' said James Hayden, senior vice president, global sales and marketing. \'It\'s competitive edge in a box.\' WinNonlin users can request a free 60-day trial by contacting +1 (919) 852-4685 or visiting. About Certara Certara is dedicated to improving human health through a broad spectrum of software products and consulting services, from molecular discovery through clinical development, with special focus on supporting translational approaches to drug development. Certara was formed by the acquisition and integration of industry leaders Tripos ( - )®, Simcyp™, and Pharsight® Corporation. Each Certara family brand focuses on a key phase within the drug discovery and development process; combined, they offer a unique set of scientific modeling, analysis, and simulation capabilities that can enable the cross-disciplinary approaches necessary for translational science initiatives. For more information, visit.
Are you currently using Excel for PK/TK analysis? We will show how to leverage Phoenix WinNonlin to streamline all of the analyses and generate all of the output needed for noncompartmental analysis, TK, PK and PK/PD studies from within a single, validatable environment. Highlights of this interactive workshop will include: • Sophisticated plotting of PK data • Calculation of key PK parameters Cmax, Tmax, AUClast, AUCinf, Clearance • Statistical summary of PK parameters in a presentation-quality report table • Save repetitive steps with re-usable analysis templates.
...'>Free Download Winnonlin Software(17.03.2019)LOUIS --(Business Wire)-- Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announces availability of a 60-day free trial of Phoenix® Connect™, a reporting tool for existing Phoenix WinNonlin® users. Phoenix Connect provides integrated, automatic report compilation, replacing existing, error-prone manual processes for copying and pasting tables, listings and figures into Microsoft ( - )® Word®. As a result, clinical trial teams can have confidence that their periodic reporting will be error-free and will not impede drug development processes and regulatory milestones.
This software solution benefits pharmaceutical and biotech R&D and clinical trial staff by offering: • Integrated connectivity between Phoenix workflows and external applications • Seamless, error-free reporting, modeling and data management • Enhanced compliance and speed to market • Minimized regulatory risk ad costly exposure resulting from data errors • Time savings associated with manual report generation (reducing effort from hours to minutes). \'While Phoenix Connect saves clinical trial teams vast amounts of time, its real value is in the way it ensures error-free data in both interim and final reports.That result has a positive impact on the business: fewer data errors means less risk at regulatory milestones and greater chance that drugs in development get to market faster and without data-related regulatory issues,\' said James Hayden, senior vice president, global sales and marketing. \'It\'s competitive edge in a box.\' WinNonlin users can request a free 60-day trial by contacting +1 (919) 852-4685 or visiting. About Certara Certara is dedicated to improving human health through a broad spectrum of software products and consulting services, from molecular discovery through clinical development, with special focus on supporting translational approaches to drug development. Certara was formed by the acquisition and integration of industry leaders Tripos ( - )®, Simcyp™, and Pharsight® Corporation. Each Certara family brand focuses on a key phase within the drug discovery and development process; combined, they offer a unique set of scientific modeling, analysis, and simulation capabilities that can enable the cross-disciplinary approaches necessary for translational science initiatives. For more information, visit.
Are you currently using Excel for PK/TK analysis? We will show how to leverage Phoenix WinNonlin to streamline all of the analyses and generate all of the output needed for noncompartmental analysis, TK, PK and PK/PD studies from within a single, validatable environment. Highlights of this interactive workshop will include: • Sophisticated plotting of PK data • Calculation of key PK parameters Cmax, Tmax, AUClast, AUCinf, Clearance • Statistical summary of PK parameters in a presentation-quality report table • Save repetitive steps with re-usable analysis templates.
...'>Free Download Winnonlin Software(17.03.2019)